KBKarl Ulrich Bayer

Karl Ulrich Bayer

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Karl Ulrich Bayer has a total of 122 co-authors. Here are the top co-authors by number of shared publications:

  • Steven J. Coultrap

    31 shared publications
  • Jonathan E. Tullis

    Department of Pharmacology, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA

    12 shared publications
  • Nicole L. Rumian

    Department of Pharmacology, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA

    12 shared publications
  • Olivia R. Buonarati

    Department of Pharmacology, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA

    10 shared publications
  • Carolyn Nicole Brown

    8 shared publications
  • Dayton J. Goodell

    Department of Pharmacology, University of Colorado, Anschutz Medical Campus, Aurora, CO 80045, USA; Program in Neuroscience, University of Colorado, Anschutz Medical Campus, Aurora, CO 80045, USA

    7 shared publications

Latest Publications

  • Open Access

    CaMKII monomers are sufficient for GluN2B binding, co-condensation, and synaptic potentiation

    by Carolyn Nicole Brown, C. Madison Barker, Carley N. Miller, Fan-Yi Chao, Jason Aoto, Steven J. Coultrap, K. Ulrich Bayer

  • Open Access

    CaMKII T286 autophosphorylation is not propagated at basal Ca 2+ levels and is required only for the induction phase of LTP

    by Fan-Yi Chao, Nicole L. Rumian, Adam P. Miller, Steven J. Coultrap, Steve L. Reichow, K. Ulrich Bayer

    SUMMARY: The Ca 2+ /calmodulin-dependent protein kinase II (CaMKII) and its autophosphorylation at T286 (P-T286) mediates long-term potentiation (LTP) of synaptic strength. CaMKII forms stable 12-meric holoenzymes, but exchange of its subunits is proposed to propagate the P-T286 state beyond dephosphorylation or degradation of individual subunits. However, a recent study questioned subunit exchange and instead proposed P-T286 propagation by trans -holoenzyme phosphorylation. We show here that both subunit exchange and trans -holoenzyme P-T286 can occur (although cis -holoenzyme P-T286 is much preferred), but that neither mechanism propagates P-T286 at basal cellular Ca 2+ levels (50-100 nM) in absence of further Ca 2+ -stimuli. Functionally, we show that after theta-burst stimulation (TBS), P-T286 is required only during the first minutes of LTP induction that prime for subsequent LTP expression, but neither for LTP expression itself nor for LTP maintenance. These results indicate that P-T286 of CaMKII does not self-perpetuate and does not mediate storage but computation of synaptic information.

  • Open Access

    The CaMKII D135N mutation blocks kinase activity and reduces GluN2B binding

    by Matthew E. Larsen, C. Madison Barker, Raul Satoshi Vargas, Steven J. Coultrap, K. Ulrich Bayer

  • Open Access

    The CaMKII D135N mutation blocks kinase activity and reduces GluN2B binding

    by Matthew E. Larsen, C. Madison Barker, Raul Satoshi Vargas, Steven J. Coultrap, K. Ulrich Bayer

    Three recent studies claimed that induction of long-term potentiation (LTP) of synaptic strength requires structural rather than enzymatic functions of the Ca 2+ /Calmodulin(CaM)-dependent protein kinase II (CaMKII). One study utilized the CaMKII D135N mutation, which was claimed to abolish enzymatic activity without affecting the structural function, i.e. binding to GluN2B. We found here that the D135N mutant indeed abolished enzymatic kinase activity and autophosphorylation at T286 (pT286). However, D135N mutation additionally reduced binding to GluN2B and prevented persistence of co-condensation with GluN2B. Similar as with the T286A mutant, GluN2B binding of the D135N mutant could be partially rescued by AS283, an inhibitor that directly enhances GluN2B binding. This partial effect on GluN2B binding has to be taken into account when using D135N to distinguish between enzymatic versus structural functions of CaMKII. Nonetheless, as discussed here, the D135N mutant indeed supports a structural rather than enzymatic CaMKII function in LTP induction.

  • Open Access

    CaMKII monomers are sufficient for GluN2B binding, co-condensation, and synaptic potentiation

    by Carolyn Nicole Brown, C. Madison Barker, Carley N. Miller, Jason Aoto, Steven J. Coultrap, K. Ulrich Bayer

    SUMMARY: Cognitive functions require synaptic plasticity, specifically long-term potentiation (LTP). LTP is thought to require CaMKII binding to the NMDA-type glutamate receptor subunit GluN2B, but this poses a major conundrum: Truncated CaMKII monomers (without the hub domain that forms 12meric holoenzymes) fail to bind GluN2B, but still potentiate synapses when made constitutively active. We hypothesized that CaMKII monomer binding to GluN2B has just eluded detection. Instead, even though full-length CaMKII monomers (with hub domain mutations) were found to indeed bind and even co-condensate with GluN2B, truncated monomers were not. Nonetheless, truncated monomers still potentiated synapses, even in neurons with GluN2B mutations that ablate CaMKII binding. However, potentiation occurred only with monomers that were made Ca 2+ -independent by artificial phosphatase-resistant thio-autophosphorylation, not by regular autophosphorylation of T286. These findings support that CaMKII binding to GluN2B is required during physiological LTP induction because it generates the phosphatase-resistant autonomous activity that mediates LTP expression.


  • Aβ impairs the LTP-related movement of endogenous CaMKII but not of exogenous GFP-CaMKII

    by Carolyn Nicole Brown, Fan-Yi Chao, Daphne Quang, Nicole L. Rumian, Mason S. Kleinjan, Steven J. Coultrap, K. Ulrich Bayer

    Amyloid β (Aβ) inhibits hippocampal long-term potentiation (LTP; a form of synaptic plasticity thought to underly learning and memory) by inhibiting the stimulation-induced synaptic accumulation of the Ca2+/calmodulin (CaM)-dependent protein kinase II (CaMKII). Notably, CaMKII inhibition rescues both CaMKII movement and LTP, indicating that CaMKII mediates both LTP and the Aβ-induced LTP impairment. Somewhat counterintuitively, we found here that overexpression of GFP-CaMKII also rescued the Aβ-induced impairment of CaMKII movement. For endogenous CaMKII, we confirmed that Aβ indeed induced impairment of movement, and that previous results with live-imaging approaches were not due to Aβ-induced dissociation of the CaMKII intrabody. For exogenous GFP-CaMKII, the effect did not depend on the expression level and was thus likely caused by the N-terminal GFP label. Surprisingly, placing the GFP label instead at the C-terminus (near the association domain) still allowed CaMKII holoenzyme formation and still protected from the Aβ-induced impairment of CaMKII movement. Thus, while our method allows replacing endogenous CaMKII with similar amounts of GFP-CaMKII, our results provide a rare example for GFP-CaMKII not recapitulating the function of endogenous CaMKII.


  • Open Access

    CaMKII mechanisms that promote pathological LTP impairments

    by Matthew E. Larsen, Nicole L. Rumian, Nidia Quillinan, K. Ulrich Bayer


  • Open Access

    The neuroprotective γ-hydroxybutyrate analog 3-hydroxycyclopent-1-enecarboxylic acid does not directly affect CaMKIIα autophosphorylation at T286 or binding to GluN2B

    by Carolyn Nicole Brown, Rachel E. Blaine, Chase Madison Barker, Steven J. Coultrap, Karl Ulrich Bayer


  • Open Access

    Oxygen/glucose-deprivation causes long-term impairment of synaptic CaMKII movement

    by Olivia R. Buonarati, Nidia Quillinan, K. Ulrich Bayer

    SUMMARY: Learning and memory are thought to require hippocampal long-term potentiation (LTP), a form of synaptic plasticity that is persistently impaired after cerebral ischemia and that requires movement of the Ca 2+ /calmodulin-dependent protein kinase II (CaMKII) to excitatory synapses. We show here that oxygen/glucose-deprivation (OGD) in cultures hippocampal neurons causes a long-lasting impairment of CaMKII movement. Notably, CaMKII inhibition at 30 min after onset of OGD prevented the impairment in CaMKII movement. Thus, CaMKII mediates both, LTP mechanisms and their ischemia-induced impairment. These findings provide a mechanism by which ischemic conditions can impair LTP and explain how CaMKII inhibition after cerebral ischemia can prevent these LTP impairments.

  • A revised view of the role of CaMKII in learning and memory

    by Karl Ulrich Bayer, Karl Peter Giese

    The Ca2+/calmodulin (CaM)-dependent protein kinase II (CaMKII) plays a fundamental role in learning and possibly also in memory. However, current mechanistic models require fundamental revision. CaMKII autophosphorylation at Thr286 (pThr286) does not provide the molecular basis for long-term memory, as long believed. Instead, pThr286 mediates the signal processing required for induction of several distinct forms of synaptic plasticity, including Hebbian long-term potentiation and depression and non-Hebbian behavioral timescale synaptic plasticity. We discuss (i) the molecular computations by which CaMKII supports these diverse plasticity mechanisms, (ii) alternative CaMKII mechanisms that may contribute to the maintenance phase of LTP and (iii) the relationship of these mechanisms to behavioral learning and memory.